The L3Harris Next Generation Aiming Laser (NGAL) (NGL-000-A1) is a rugged, ultra-compact and lightweight system designed to be compatible with all generations of night vision devices.

The size of a credit card, NGAL uses an advanced illuminator design to achieve a more uniform near infrared illuminator beam for increased situational awareness. High-efficiency electronics support increased system performance at reduced size, weight and power.

Neutrophil gelatinase-associated lipocalin (NGAL) is a 25 kDa protein belonging to the lipocalin superfamily. It was initially found in activated neutrophils, however, many other cells, like kidney tubular cells, may produce NGAL in response to various insults.

The L3Harris NGAL is a rugged, ultra-compact and lightweight system designed to be compatible with all generations of night vision devices. NGAL uses an advanced illuminator design to achieve a more uniform Near Infrared illuminator beam for increased Situation Awareness.

Neutrophil gelatinase-associated lipocalin (NGAL) is an emerging biomarker for the early detection of AKI. Studies have shown NGAL to be a highly induced protein in the kidney after ischemic or nephrotoxic injury.

NGAL is produced in the distal nephron and its synthesis is up-regulated in response to kidney injury. NGAL is an ion-transporting agent. Markers of damage are potentially better than functional markers. NGAL is also a powerful marker of kidney disease progression.

Urinary neutrophil gelatinase-associated lipocalin (NGAL) has shown promise in differentiating acute tubular necrosis (ATN) from other types of acute kidney injuries (AKIs) in cirrhosis, particularly hepatorenal syndrome (HRS).

2023年11月20日 · The NGAL features a revolutionary advancement in laser technology and offers reduced Size, Weight, and Power (SWaP). The NGAL has an aluminum frame for smaller dimensions and offers multiple modes of operation: visible …

2022年11月1日 · The results suggested that the serum NGAL levels were elevated ≥ 25% from baseline within 24 h in patients with CI-AKI. Notably, serum NGAL levels had better prognostic values than serum creatinine levels. NGAL could be used as a biomarker for predicting CI-AKI following surgical procedures like cardiac coronary catheterization [31].

The evidence for the role of NGAL measurements in a variety of clinical situations leading to AKI (cardiac surgery, kidney transplantation, contrast nephropathy, haemolytic uraemic syndrome and in the intensive care setting) or to CKD (lupus nephritis, glomerulonephritides, obstruction, dysplasia, polycystic kidney disease, IgA nephropathy) is ...